Functional Dyspepsia: Impaired Fundic Accommodation
- PMID: 11096589
- DOI: 10.1007/s11938-000-0042-7
Functional Dyspepsia: Impaired Fundic Accommodation
Abstract
Functional dyspepsia is a heterogeneous disorder in which distinct pathophysiological abnormalities are present in subgroups of patients. Accommodation of the proximal stomach to a meal is impaired in 40% of patients with functional dyspepsia. This is associated with symptoms of early satiety and weight loss. The presence of early satiety as a relevant or severe symptom is a good predictor of impaired accommodation. Gastric barostat or proximal gastric ultrasound may confirm the presence of impaired accommodation after a meal. Sophisticated analysis of scintigraphic gastric emptying images or a simple caloric drinking test are under investigation in the diagnosis of impaired accommodation. It seems logical to have patients eat more frequent, smaller sized meals. Cisapride is the only well-evaluated form of pharmacological treatment for this condition, and has been withdrawn from the US market (see Important Note under Treatment, below). Small or preliminary studies suggest some benefit from buspirone or selective serotonin reuptake inhibitors (SSRIs).
Similar articles
-
Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.Gut. 2003 Sep;52(9):1271-7. doi: 10.1136/gut.52.9.1271. Gut. 2003. PMID: 12912857 Free PMC article. Clinical Trial.
-
Role of impaired gastric accommodation to a meal in functional dyspepsia.Gastroenterology. 1998 Dec;115(6):1346-52. doi: 10.1016/s0016-5085(98)70012-5. Gastroenterology. 1998. PMID: 9834261
-
The proximal stomach and postprandial symptoms in functional dyspeptics.Am J Gastroenterol. 2002 Jan;97(1):40-8. doi: 10.1111/j.1572-0241.2002.05421.x. Am J Gastroenterol. 2002. PMID: 11811168 Clinical Trial.
-
The role of gastric accommodation in the pathophysiology of functional dyspepsia.Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5 Suppl 1):23-8. Eur Rev Med Pharmacol Sci. 2005. PMID: 16457126 Review.
-
Gastric accommodation: Physiology, diagnostic modalities, clinical relevance, and therapies.Neurogastroenterol Motil. 2021 Dec;33(12):e14213. doi: 10.1111/nmo.14213. Epub 2021 Aug 1. Neurogastroenterol Motil. 2021. PMID: 34337824 Review.
Cited by
-
Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.J Gastroenterol. 2012 Aug;47(8):862-71. doi: 10.1007/s00535-012-0625-9. Epub 2012 Jul 6. J Gastroenterol. 2012. PMID: 22766746 Review.
-
Reconsideration of the Gastroparetic Syndrome.Curr Gastroenterol Rep. 2023 Apr;25(4):75-90. doi: 10.1007/s11894-023-00865-w. Epub 2023 Apr 1. Curr Gastroenterol Rep. 2023. PMID: 37004633 Review.
-
Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extract.Anim Cells Syst (Seoul). 2017 Aug 18;21(4):255-262. doi: 10.1080/19768354.2017.1357660. eCollection 2017. Anim Cells Syst (Seoul). 2017. PMID: 30460076 Free PMC article.
-
Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.Nat Rev Rheumatol. 2023 Mar;19(3):166-181. doi: 10.1038/s41584-022-00900-6. Epub 2023 Feb 6. Nat Rev Rheumatol. 2023. PMID: 36747090 Review.
-
Serotonergic modulating drugs for functional gastrointestinal diseases.Br J Clin Pharmacol. 2002 Jul;54(1):11-20. doi: 10.1046/j.1365-2125.2002.01612.x. Br J Clin Pharmacol. 2002. PMID: 12100220 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources